Results 31 to 40 of about 4,227,388 (391)
25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug [PDF]
, 2014 Introduction. The use of novel psychoactive substances (NPSs) has rapidly increased as well as their online availability. The aim of this paper is to provide a comprehensive review of the nature and the risks associated with 25C-NBOMe, which has recently
BERSANI, FRANCESCO SAVERIO +10 more
core +5 more sources
Frontiers in Behavioral Neuroscience, 2022 Conditioned stimuli (CS) associated with alcohol ingestion are thought to play a role in relapse by producing a craving that in turn increases motivation to drink which increases ethanol-seeking and disrupts other ongoing behavior. Alternatively, such CS
Brett C. Ginsburg +3 more
doaj +1 more source
Bioengineered Textiles and Nonwovens – the convergence of bio-miniaturisation and electroactive conductive polymers for assistive healthcare, portable power and design-led wearable technology [PDF]
, 2009 Today, there is an opportunity to bring together creative design activities to exploit the responsive and adaptive ‘smart’ materials that are a result of rapid development in electro, photo active polymers or OFEDs (organic thin film electronic devices),
Oliver, Raymond +2 more
core +3 more sources
Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects
Neurology International, 2022 As tranquilizers, benzodiazepines have a wide range of clinical uses. Recently, there has been a significant rise in the number of novel psychoactive substances, including designer benzodiazepines.
Amber N. Edinoff +9 more
doaj +1 more source
SLAS technology, 2018 Artificial intelligence holds great promise in transforming how drugs are designed and patients are treated. In a study recently published in Science Translational Medicine, a unique artificial intelligence platform makes efficient use of small ...
M. Rashid, E. Chow
semanticscholar +1 more source
Designer receptor technology for the treatment of epilepsy
EBioMedicine, 2019 Epilepsy remains refractory to medical treatment in ~30% of patients despite decades of new drug development. Neurosurgery to remove or disconnect the seizure focus is often curative but frequently contraindicated by risks of irreversible impairment to ...
Andreas Lieb +2 more
doaj +1 more source
Detection of Drugs of Abuse by Raman Spectroscopy [PDF]
, 2011 Raman spectroscopy can provide rapid, sensitive, non-destructive analysis of a variety of drug types (e.g. amphetamines, alkaloids, designer drugs and date rape drugs). This review concentrates on developments in the past 15 years.
Ali +45 more
core +1 more source
Putting forward a model for the role of the cerebellum in cocaine-induced pavlovian memory
Frontiers in Systems Neuroscience, 2023 Substance Use Disorder (SUD) involves emotional, cognitive, and motivational dysfunction. Long-lasting molecular and structural changes in brain regions functionally and anatomically linked to the cerebellum, such as the prefrontal cortex, amygdala ...
Ignasi Melchor-Eixea +5 more
doaj +1 more source
Química Nova, 2016 Drug trafficking and the introduction of new drugs onto the illicit market are one of the main challenges of the forensic community. In this study, the chemical profile of a new designer drug, 2-(4-iodine-2,5-dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl ...
Pâmella F. dos Santos +11 more
doaj +1 more source
E-BioFlow: Different Perspectives on Scientific Workflows [PDF]
, 2008 We introduce a new type of workflow design system called\ud e-BioFlow and illustrate it by means of a simple sequence alignment workflow. E-BioFlow, intended to model advanced scientific workflows, enables the user to model a workflow from three ...
Breit, T. +4 more
core +2 more sources